ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutritional Epidemiology
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1641276
Global, regional, and national burden of high body-mass index-related cancers and associated preventable life expectancy loss from1990 to 2021
Provisionally accepted
- 1Guangdong Women and Children Hospital, Guangzhou, China
- 2Jinan University, Guangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
A high Body Mass Index (BMI) is a key modifiable risk factor for cancer incidence. Therefore, it is essential to monitor the evolving trends and impact of cancer linked to high BMI and to formulate suitable strategies to address this issue. This study aims to analyze, from 1990 to 2021, the burden and temporal trends of cancer attributable to BMI as well as their impact on life expectancy, with major patterns highlighted by sex, socio-demographic index (SDI), and geographical region. Utilizing data from the Global Burden of Disease Study 2021, which incorporates 328,938 data sources, we conducted a comprehensive analysis of cancer attributable to high BMI, specifically investigating mortality rates and disability-adjusted life years (DALYs) from 1990 to 2021. Age-standardized rates were used to facilitate cross-regional comparisons, accounting for differences in population size and demographics. In addition, we used the abridged period life table to estimate the impact of high BMI-related cancer on life expectancy. The age-standardized death and DALY rates of cancer linked to high BMI increased (average annual percent change, 0.4 (95% UI: 0.4–0.5) for mortality and 0.5 (95% UI: 0.4–0.6) for DALY) from 1990 to 2021. The alarming proportional increase in deaths from the main cancer associated with high BMI was observed among younger age groups (<45 years) from 1990 to 2021. In 2021, the most significant increases in life expectancy at birth were observed in regions with a high socio-demographic index, with gains of 0.12 (95% CI: -0.45–0.69) years for males and 0.19 (95% CI: -0.35–0.73) years for females, respectively. It is predicted that the age-standardized death rate of cancer attributable to high BMI will increase from 3.31(3.29-3.33) in 2021 to 3.32(1.27-5.37) by 2046 in males, and from 4.36(4.38-4.39) to 4.90(1.96-7.86) in females. The age-standardized mortality and DALY rates of cancer linked to high BMI have increased substantially, with significant differences across sex, geographic region, and SDI. Interventions aimed at reducing exposure are crucial not only to mitigate the cancer burden attributable to high BMI effectively, but also to yield modest gains in life expectancy.
Keywords: Cancer, High BMI, death, Disability-adjusted life years, Life Expectancy
Received: 06 Jun 2025; Accepted: 04 Aug 2025.
Copyright: © 2025 Huang, Wang, Li and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ling Huang, Guangdong Women and Children Hospital, Guangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.